Stabilized atypical antipsychotic formulation

Details Stabilized atypical antipsychotic formulation Stabilized atypical antipsychotic formulation

2011-08-23

2011-08-23

Wax, Robert A (Department: 1615)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S259410, C514S254040, C514S254060, C514S317000, C514S321000, C424S484000, C424S489000

Reexamination Certificate

active

08003637

ABSTRACT:
A pharmaceutical composition that contains an atypical antipsychotic drug and succinic acid, fumaric acid or a mixture of succinic acid and fumaric acid.

REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4034758 (1977-07-01), Theeuwes
patent: 4036228 (1977-07-01), Theeuwes
patent: 4077407 (1978-03-01), Theeuwes et al.
patent: 4612008 (1986-09-01), Wong et al.
patent: 4663147 (1987-05-01), DePrince
patent: 4783337 (1988-11-01), Wong et al.
patent: 4786505 (1988-11-01), Lovgren et al.
patent: 4873337 (1989-10-01), Sih et al.
patent: 4879288 (1989-11-01), Warawa et al.
patent: 4984240 (1991-01-01), Keren-Zvi et al.
patent: 5002776 (1991-03-01), Geoghegan et al.
patent: 5071607 (1991-12-01), Ayer et al.
patent: 5229382 (1993-07-01), Chakrabarti et al.
patent: 5314697 (1994-05-01), Kwan et al.
patent: 5529791 (1996-06-01), Deboeck et al.
patent: 5563134 (1996-10-01), Fischer et al.
patent: 5627178 (1997-05-01), Chakrabarti et al.
patent: 5654005 (1997-08-01), Chen et al.
patent: 5948437 (1999-09-01), Parikh et al.
patent: 6099859 (2000-08-01), Cheng et al.
patent: 6251895 (2001-06-01), Larsen et al.
patent: 6923984 (2005-08-01), Remon
patent: 2004/0180088 (2004-09-01), Dudhara et al.
patent: 2005/0158383 (2005-07-01), Boehm et al.
patent: 2007/0196491 (2007-08-01), Venkatesh
patent: 2007/0244093 (2007-10-01), Boehm et al.
patent: 2008/0081069 (2008-04-01), Prasad et al.
patent: 2008/0221079 (2008-09-01), Jansen
patent: 2008/0287418 (2008-11-01), Brown et al.
patent: 2009/0004281 (2009-01-01), Nghiem et al.
patent: 2009/0317473 (2009-12-01), Naringrekar et al.
patent: 2005041935 (2005-05-01), None
patent: 2006088305 (2006-08-01), None
patent: 2007090091 (2007-08-01), None
patent: 2008060228 (2008-05-01), None
patent: 2010011232 (2010-01-01), None
61st ed. of Physician's Desk Reference; entry for Risperdal; pp. 1676-1688; Thomson PDR; Montvale, NJ; 2007.
61st ed. of Physician's Desk Reference; entry for Abilify; pp. 2450-2455; Thomson PDR; Montvale, NJ; 2007.
61st ed. of Physician's Desk Reference; entry for Geodon; pp. 2529-2535; Thomson PDR; Montvale, NJ; 2007.
L.W. Young, International Search Report in PCT/US08/75333, 1 page, Nov. 19, 2008, USPTO.
A. Wittman-Regis, International Preliminary Report on Patentability in PCT/US08/75333, 4 pages, Jan. 25, 2011, Int'l Bureau of WIPO, Geneva, Switzerland.
L.W. Young, Written Opinion in PCT/US08/75333, 3 pages, Nov. 19, 2008, USPTO.
Package Insert for SEROQUEL XR, 29 pages, AstraZeneca Pharmaceuticals, Wilmington, DE, May 2007.

Affiliated with

Also associated with

Rating

Stabilized atypical antipsychotic formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stabilized atypical antipsychotic formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized atypical antipsychotic formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2677557